Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Prostatic Neoplasms
  • Radiosurgery

abstract

  • The use of SBRT and proton beam therapy for localized prostate cancer has increased over time. Despite men of lower disease stage undergoing SBRT, SBRT was found to be associated with greater toxicity but lower health care costs compared with IMRT and proton beam therapy. Cancer 2016;122:2496-504. © 2016 American Cancer Society.

publication date

  • August 15, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4974119

Digital Object Identifier (DOI)

  • 10.1002/cncr.30101

PubMed ID

  • 27224858

Additional Document Info

start page

  • 2496

end page

  • 504

volume

  • 122

number

  • 16